Skip to content
CompletedNot applicable

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery

NCT06530706 · Zhejiang Cancer Hospital

Closed to entry
Status
Not accepting participants
Not applicable
Phase
185
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Whether esketamine can reduce anxiety status in patients with anxiety

    Measured over 1 day before surgery, 3 days after surgery, 1 month after surgery

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 70 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Patients undergoing abdominal tumor surgery; * older than 18 years old and younger than 70 years old; * ASA grade I-III; * Hamilton anxiety scale ≥ 8. Exclusion Criteria: * Having serious mental illness before surgery or on antipsychotic medication in the two weeks before screening; * Severe organ function lesions such as heart failure (left ventricular ejection fraction \<30%), myocardial infarction, kidney failure (requiring kidney replacement therapy), liver function impairment (Child-Pugh grade C), etc. * Patients arranged to receive general anesthesia combined with epidural anesthesia patients; * Patients who cannot communicate, read or write due to visual, auditory, language or other reasons; * Patients allergic to ketamine; * Patients refused to use postoperative self-controlled intravenous analgesia pump; * Patients refused to participate in the study.

Where

1 study site

FacilityCityRegionCountry
Zhejiang cancer hospitalHangzhouZhejiangChina

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT06530706 on ClinicalTrials.gov →

Last updated in the registry 2025-09-16. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits